Sitagliptin
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3868 publications
Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study.
Journal: BMJ (Clinical research ed.)
Published: August 05, 2026
Correction to: Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 05, 2026
Are SGLT2 inhibitors really associated with increased urinary tract infection risk? A trial-level meta-analysis across type 2 diabetes, heart failure, and chronic kidney disease.
Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Published: June 30, 2026
Corrigendum to "Antidiabetic sitagliptin influences tissue regeneration by affecting progenitor cells" [Biomed. Pharmacother. 189 (2025) 118279].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 29, 2026
Coimmobilized Pyridoxal 5'-Phosphate and Aminotransferase in a Hydrogen-Bonded Organic Framework for Sustainable Synthesis of Sitagliptin.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: June 24, 2026
Fate of Trace Organic Contaminants in the Hyporheic Zone: A Laboratory-Scale Column Experiment.
Journal: Environmental science & technology
Published: June 16, 2026
Economic evaluation of liraglutide versus sitagliptin in the treatment of type 2 diabetes mellitus inadequately controlled with metformin.
Journal: Frontiers in clinical diabetes and healthcare
Published: June 11, 2026
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Left Ventricular Global Longitudinal Strain in Adults with Type 2 Diabetes Mellitus: A Systematic Review.
Journal: Journal of clinical medicine
Published: June 10, 2026
Sitagliptin to Patients With Postprandial Hypotension Without Diabetes.
Journal: Geriatrics & gerontology international
Published: June 09, 2026
Correction to: Ertugliflozin improves animal behaviours associated with oxidative stress and inflammation in a BTBR T + Itpr3tf/J mouse model of autism.
Journal: Brain communications
Published: June 08, 2026
Last Updated: 09/26/2026